Point-of-care monitoring of oral anticoagulation therapy in children: Comparison of the CoaguChek XS® system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95)

Thrombosis and Haemostasis

Volumn 102, Issue 1, 2009, Pages 159-165

  Greenway, Anthea ^a,b   Ignjatovic, Vera ^b   Summerhayes, Robyn ^b   Newall, Fiona ^a,b   Burgess, Janet ^a   DeRosa, Lydia ^a   Monagle, Paul ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Children; CoaguChek XS ; Point of care; Reference thromboplastin; Venous INR; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; THROMBOPLASTIN; WARFARIN;

ACCURACY; ADOLESCENT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING; CARDIOMYOPATHY; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ELECTROCHEMISTRY; FEMALE; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LABORATORY; MALE; MOYAMOYA DISEASE; PATIENT MONITORING; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTHROMBIN TIME; PULMONARY HYPERTENSION; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ADOLESCENT; ANTICOAGULANTS; CAPILLARIES; CHILD; CHILD, PRESCHOOL; DRUG MONITORING; FEMALE; HUMANS; INFANT; INTERNATIONAL NORMALIZED RATIO; MALE; POINT-OF-CARE SYSTEMS; PROTHROMBIN TIME; REFERENCE STANDARDS; THROMBOPLASTIN; VEINS; WARFARIN;

EID: 67749117937     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-01-0056     Document Type: Article

References (27)

1. Greenway A, Massicotte MP, Monagle P. Neonatal thrombosis and its treatment. Blood Rev 2004; 18: 75-84.
2. Monagle P, Chalmers E, Chan A, et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 887S-968S.
3. Leichsenring I, Plesch W, Unkrig V, et al. Multicentre ISI assignment and calibration of the INR measuring range of a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Thromb Haemost 2007; 97: 856-861.
4. Bereznicki LR, Jackson SL, Peterson GM, et al. Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring. J Clin Pathol 2007; 60: 311-314.
5. Bauman ME, Black KL, Massicotte MP, et al. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Thromb Haemost 2008; 99: 1097-1103.
6. Marzinotto V, Monagle P, Chan A, et al. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatr Cardiol 2000; 21: 347-352.
7. Monagle P, Barnes C, Ignjatovic V, et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost 2006; 95: 362-372.
8. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-1657.
9. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-172.
10. Williams VK, Griffiths ABM. Acceptability of CoaguChek S and CoaguChek XS generated international normalised ratios against a laboratory standard in a paediatric setting. Pathology 2007; 39: 575-579.
11. Tripodi A, Poller L, van den Besselaar AM, et al. A proposed scheme for calibration of international reference preparations of thromboplastin for the prothrombin time. On behalf of the Subcommittee on Control of Anticoagulation. Thromb Haemost 1995; 74: 1368-1369.
12. Hirsh J DJ, Anderson DR, Poller L, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119: 8S-21S.
13. Grau E, Tenias JM, Olaso MA, et al. Monitoring oral anticoagulant treatment from plasma stored for up to 48 hours and frozen plasma. Haematologica 1999; 84: 633-636.
14. Dacie JV LS, Bain BJ, Bates I. Investigation of haemostasis. In: Dacie and Lewis's Practical Haematology. Ninth Edition ed: Churchill Livingstone; 2001.
15. WHO. WHO Guidelines for Thromboplastins and Plasma Used to Control Anticoagulant Therapy. WHO Technical Report Series 889 1999; Annex 3: pp. 64-93.
16. Monagle P, deVeber G, Massicotte M. Chapter 14: Vitamin K Antagonists: Warfarin and Acenocoumarol Therapy. In: Andrew's Pediatric Thromboembolism and Stroke. Third ed. Hamilton, Ontario: BC Decker; 2006.
17. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989; 45: 255-268.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
19. Tripodi A, Arbini AA, Chantarangkul V, et al. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thromb Haemost 1993; 70: 921-924.
20. Ignjatovic V, Barnes C, Newall F, et al. Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio. Thromb Haemost 2004; 92: 734-737.
21. Plesch W, van den Besselaar AM. Validation of the international normalized ratio (INR) in a new point-of-care system designed for home monitoring of oral anticoagulation therapy. Int J Lab Hematol 2009; 31: 20-25.
22. Ansell J HJ, Hylek E, Jacobson A, et al. Pharmacology and Management of the Vitamin K Antagonists. CHEST 2008; 133(American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition): 160S-198.
23. Tripodi A. International collaborative study for the calibration of a proposed reference preparation for Thromboplastin, human recombinant. WHO Expert committee on biological standards, Geneva. Thromb Haemost 1998; 79: 439-443.
24. Baker RI, Coughlin PB, Gallus AS, et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004; 181: 492-497.
25. Baker P, Gleghorn A, Tripp T, et al. Reversal of asymptomatic over-anticoagulation by orally administered vitamin K. Br J Haematol 2006;133: 331-336.
26. Streif W, Andrew M, Marzinotto V, et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999; 94: 3007-3014.
27. Newall F, Savoia H, Campbell J, et al. Anticoagulation clinics for children achieve improved warfarin management. Thromb Res 2004; 114: 5-9.